President Donald Trump, his Treasury secretary and his choice to lead the Federal Reserve believe they can coax the U.S. economy into partying like it’s 1999.
Pacira BioSciences (NASDAQ:PCRX) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight what CEO Frank Lee described as a “transformative year,” pointing to renewed EXPAREL volume momentum, strengthened intellectual property protection, expanded reimbursement coverage, and a pipeline entering a “data-rich” period. Lee said the company
Definitive Healthcare (NASDAQ:DH) reported fourth-quarter 2025 results that management said landed at or above the high end of its guidance ranges, while outlining continued work to improve retention and rebuild a path to sustainable revenue growth. Q4 results and full-year performance Total revenue in the fourth quarter was $61.
PENN Entertainment (NASDAQ:PENN) executives highlighted improving profitability trends across both the company’s retail casino portfolio and its interactive segment during the company’s fourth quarter 2025 earnings call, while also outlining expectations for meaningful free cash flow generation and deleveraging in 2026. Retail results and property-level trends Chief
Intchains Group (NASDAQ:ICG) used its fourth-quarter and full-year 2025 earnings call to highlight a year marked by cryptocurrency market volatility, new mining product launches, and continued expansion of its Ethereum (ETH) treasury and staking initiatives. CFO Charles Yan said the company’s core businesses remain the sale of altcoin
